Assay News and Research

RSS

INDIGO Biosciences expands reporter assay capabilities with new Transrepression Assay Services

INDIGO Biosciences today announced the launch of its Transrepression Assay Services, expanding the company’s cell-based reporter assay capabilities for drug discovery teams studying pathway cross-talk, selective modulation, and transcription factor-mediated gene suppression.

From INDIGO Biosciences, Inc. 11 May 2026

Non-invasive swab test offers fast, accurate tuberculosis detection worldwide

A portable molecular test, MiniDock MTB, detected pulmonary tuberculosis rapidly and accurately across seven high-burden countries, using sputum or tongue swab samples. The study suggests the low-cost, battery-operated platform could expand near-point-of-care TB diagnosis in low-resource settings, although real-world implementation and drug-resistance integration still need evaluation.

10 May 2026

Advanced 3D heart models could transform cardiovascular drug discovery

Cardiovascular disease remains a leading global health burden, yet many preclinical systems still struggle to predict how candidate drugs will perform in the human heart.

10 May 2026

Researchers uncover how bacterial toxin damages colon lining cells to trigger cancer

Since a landmark 2009 study, researchers have known that a common gut bacterium, Bacteroides fragilis, drives colon tumor formation, potentially leading to colorectal cancer, by secreting a toxin that damages the lining of the colon.

8 May 2026

Infectious H5N1 virus detected in dairy farm air

Findings from California dairy farms show H5N1 in air and wastewater, indicating overlooked transmission routes and implications for outbreak management.

8 May 2026

Blood test may improve early tuberculosis detection among household contacts

Household contacts of people with tuberculosis (TB) have a high risk of getting TB themselves, at around 2 percent. It is currently difficult to detect TB in its early stages, or predict who will go on to have TB, and therefore preventive treatment is not widely used.

7 May 2026

Cranberry juice may help stop antibiotic resistance in UTIs

Cranberry juice potentiates fosfomycin against UPEC, lowering resistance rates and modifying bacterial absorption pathways for improved antibiotic efficacy.

7 May 2026

New discovery challenges a decades-old assumption in HIV biology

Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect resting immune cells.

6 May 2026

Ultrasensitive test detects protein clumps to diagnose rare dementia subtype

Dementia affects over 57 million people worldwide, a number expected to nearly double in the next 20 years.

5 May 2026

Marigold flower as a sustainable plant protein for food innovation

Marigold flower proteins exhibit solubility, emulsifying, and antioxidant properties with potential applications in food formulation.

5 May 2026

CDC HoSt-TT certification for Siemens Healthineers total testosterone test expands patient access to gold standard equivalent results

Siemens Healthineers announced its Atellica IM Testosterone II (TSTII) assay has achieved certification through the Centers for Disease Control and Prevention (CDC) Hormone Standardization Program for Total Testosterone (HoSt-TT).

From Siemens Healthineers 5 May 2026

New genomic study tracks rare blood disease in children

Aplastic anemia is a rare, life-threatening blood disorder where patients are unable to make enough blood cells due to the immune system's attack on blood stem cells. The condition can progress to myelodysplastic syndrome (MDS) and leukemia. A study led by scientists at St. Jude Children's Research Hospital, with multiple collaborating institutions, used state-of-the-art genomic techniques to profile 619 children and adults with aplastic anemia.

4 May 2026

Identifying the ages when Alzheimer’s biomarkers sharply change

New research identifies critical ages for Alzheimer's biomarkers, enhancing screening strategies and understanding neurodegeneration across the aging spectrum.

1 May 2026

Food timing may shape how T cells respond to infection and therapy

Short-term nutritional state can reshape T cell metabolism, with post-meal lipid metabolism enhancing T cell metabolic capacity, cytokine production, and persistence after activation. The study identifies triglyceride-rich chylomicrons as key drivers of this effect, suggesting nutritional timing may matter for immune monitoring, vaccination research, and cell-therapy manufacturing.

30 Apr 2026

How multi-omics is changing what scientists can see in the human immune system

Human systems immunology is using multi-omics, single-cell tools, spatial technologies, and AI to decode immune responses across real-world human cohorts. The review highlights major opportunities for biomarker discovery and precision medicine, while stressing the need for rigorous study design, validation, and careful interpretation.

29 Apr 2026

Wearable sweat sensor tracks vitamin levels in real time

Researchers developed a wearable electrochemical patch that detects six vitamins in sweat at nanomolar levels, combining sweat induction, microfluidic sampling, wireless readout, and pH/ionic-strength calibration. Human testing focused mainly on vitamin B9, showing sweat levels rose after supplementation or a vitamin B9-rich diet and correlated with serum levels, supporting future use for non-invasive nutrition trend monitoring.

28 Apr 2026

New imaging method maps DNA replication forks with single-cell resolution

Researchers at The University of Texas MD Anderson Cancer Center have developed a new imaging method, known as RF-SIRF, that quantitatively detects and maps reversed DNA replication forks with single-cell resolution

28 Apr 2026

New blood filtering treatment safely extends pregnancy in severe preeclampsia

Cedars-Sinai Health Sciences University investigators have developed and successfully tested a new treatment for pregnant women with severe early preeclampsia, a leading cause of premature birth as well as maternal and fetal death.

27 Apr 2026

Natural compound obakulactone shows therapeutic potential for rheumatoid arthritis

A new study published in Engineering reveals that obakulactone (OL), a natural tetracyclic triterpenoid isolated from Phellodendri cortex, exerts a therapeutic effect on rheumatoid arthritis (RA) by promoting the degradation of acyl coenzyme A thioesterase 1 (ACOT1) via the ubiquitin‒proteasome pathway and restoring the homeostasis of unsaturated fatty acids.

25 Apr 2026

Elevated Lp(a) levels associated with residual cardiovascular risk

New data analyzing more than 20,000 patients from three major NIH studies show that elevated Lipoprotein(a) [Lp(a)] is associated with residual cardiovascular risk and warrants aggressive risk reduction.

24 Apr 2026